Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

powder of particles containing itraconazole

Based on

1 Patents
2015 Most recent source

Composition

1

cis-2-sec-butyl-4-[4-(4-{4-[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4- ylmethoxy]phenyl}piperazin-1-yl)phenyl]-2,4-dihydro-1,2,4-triazol-3-one

itraconazole
Type Single Compound
Formula C35H38Cl2N8O4
Role raw materials
2

D-(-)-mannitol

D-mannitol mannitol
Type Single Compound
Formula C6H14O6
Role raw materials
3

polyoxyethylene stearate

Type Complex Compound
Formula
Role layer

Properties

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • polyoxyethylene stearate
  • cis-2-sec-butyl-4-[4-(4-{4-[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4- ylmethoxy]phenyl}piperazin-1-yl)phenyl]-2,4-dihydro-1,2,4-triazol-3-one
  • D-(-)-mannitol
Product

powder of particles containing itraconazole

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial